🇺🇸 FDA
Patent

US 10125167

Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics

granted A61KA61K31/43A61K31/431

Quick answer

US patent 10125167 (Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/43, A61K31/431, A61K38/00, A61K38/08